Not available
Quote | Evoke Pharma Inc. (NASDAQ:EVOK)
Last: | $0.475 |
---|---|
Change Percent: | 1.62% |
Open: | $0.424 |
Close: | $0.475 |
High: | $0.5 |
Low: | $0.424 |
Volume: | 11,358 |
Last Trade Date Time: | 05/31/2024 03:00:00 am |
News | Evoke Pharma Inc. (NASDAQ:EVOK)
SOLANA BEACH, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced that its abstra...
2024-05-15 09:57:02 ET More on Evoke Pharma Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Evoke Pharma Historical earnings data for Evoke Pharma Financial information for Evoke Pharma Read the full...
Message Board Posts | Evoke Pharma Inc. (NASDAQ:EVOK)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $EVOK News Article - USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMO | whytestocks | investorshangout | 12/07/2022 1:35:48 PM |
whytestocks: $EVOK News Article - Evoke Pharma Recognizes Gastroparesis Awareness Month through its | whytestocks | investorshangout | 08/01/2022 7:35:55 PM |
znewcar1: ML2.75 MH3.49 flat and no vol | znewcar1 | investorshangout | 07/21/2022 4:01:32 AM |
whytestocks: $EVOK News Article - Evoke Pharma Expands IP Portfolio with Addition of Canadian Patent | whytestocks | investorshangout | 07/06/2022 2:55:53 PM |
Same here with me! I never caught COVID | subslover | investorshub | 06/16/2022 9:44:50 PM |
News, Short Squeeze, Breakout and More Instantly...
SOLANA BEACH, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily o...
SOLANA BEACH, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced that its abstra...
114% year-over-year increase in net product sales 70% prescriber growth in Q1 2024 compared to Q4 2023 Growing sales metrics reaffirms company’s $14M net revenue guidance for 2024 SOLANA BEACH, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a ...